Eishi Ashihara, MD, PhD¹, Ryoko Oki^1*, Natsuki Imayoshi^1*, Makoto Yoshioka, PhD^2*, Jeffrey Strovel, PhD^2*, Ayako Honjo^1*, Yumi Sakai^1*, Tetsuya Takada, BS^1*, Jay Chauhan, PhD^3*, Mithun Raje, PhD^3*, Steven Fletcher, PhD^3* and Kazuyuki Takata, PhD^1*

¹Department of Clinical and Translational Physiology, Kyoto Pharmaceutical University, Kyoto, Japan
²ConverGene LLC, Gaithersburg, MD
³School of Pharmacy, University of Maryland, Baltimore, MD

Janice Chen, PhD^1*, Christopher L. Brooks, PhD¹, Peter McDonald^1*, Jonathan D. Schwartz, MD¹, Rebecca S. Schneider^1*, Keiichi Sakakibara, PhD^2*, Naoya Saito, PhD^2*, Takuji Sato, MSc^2*, Takumi Kawabe, MD, PhD^2* and Eric K. Rowinsky, MD^1*

¹Stemline Therapeutics, Inc., New York, NY
²CanBas Co., Ltd., Numazu, Japan

Katherine Sullivan^1*, Kimberly Cramer-Morales^1*, Daniel L McElroy^2*, David Ostrov^2*, Kimberly Haas^3*, Margaret Nieborowska-Skorska^1*, Wayne Childers^3*, Alexander Mazin^4*, Robert A Hromas², Richard Pomerantz^1* and Tomasz Skorski¹

¹Temple University School of Medicine, Philadelphia, PA
²University of Florida & Shands, Gainesville, FL
³Temple University School of Pharmacy, Philadelphia
⁴Drexel University, Philadelphia, PA

Matko Kalac, MD, PhD¹, Michael Mangone, PhD^2*, Alison Rinderspacher, PhD^3*, Shi-Xian Deng, PhD^3*, Luigi Scotto, PhD^4*, Jeremie Vendome, PhD^5*, Mukesh Bansal, PhD^5*, Andrea Califano, PhD^6*, Donald Landry, MD, PhD^3* and Owen A. O'Connor, MD, PhD⁴

¹Department of Hematology and Oncology, Columbia University Medical Center, New York, NY
²Department of Medicine and Experimental Therapeutics, Columbia University Medical Center, New York, NY
³Department of Medicine - Nephrology, Columbia University Medical Center, New York, NY
⁴Center for Lymphoid Malignancies, Department of Medicine, Columbia University Medical Center, New York, NY
⁵Department of Systems Biology, Columbia University Medical Center, New York, NY
⁶Department of Biomedical Informatics and Joint Centers for Systems Biology, Columbia University, New York, NY

Barbara Muz, PhD, MSc¹, Pilar De La Puente, PhD¹, Micah John Luderer, BS, MS¹, Farideh Ordikhani^2* and Abdel Kareem Azab, BPharm, PhD¹

¹Department of Radiation Oncology, Cancer Biology Division, Washington University in Saint Louis School of Medicine, Saint Louis, MO
²Radiation Oncology, Washington Univeristy in St. Louis, Saint Louis

Laura Christine Kickham, BSc^1,2,3*, Anthony M. McElligott, PhD^2*, Adriele Prina-Mello, PhD^1,3*, Elisabeth A. Vandenberghe, MB, PhD^2,4, Yuri Volkov, MD, PhD^1,3* and Paul Browne, MD^2,4

¹Institute of Molecular Medicine, Department of Clinical Medicine, Trinity College, Dublin, Ireland
²The John Durkan Leukaemia Laboratories, Institute of Molecular Medicine, Trinity College, Dublin, Ireland
³Centre for Research on Adpative Nanostructure and Nanodevices (CRANN), Trinity College, Dublin, Ireland
⁴Department of Haematology, St James's Hospital, Dublin, Ireland

Joseph Bellairs^1*, Ravand Samaeekia^1,2*, Handan Acar, PhD^2*, Matthew Tirrell, PhD^2* and James LaBelle, MD, PhD³

¹Department of Pediatrics, Section of Hematology/Oncology, University of Chicago, Chicago, IL
²Institute for Molecular Engineering, University of Chicago, Chicago, IL
³Department of Pediatrics, Section of Hematology/Oncology, University of Chicago Medical Center, Chicago, IL

Tyler Sweeney^1*, Stephen E Spurgeon, MD², Jeffrey W. Tyner, PhD³, Anupriya Agarwal, PhD⁴, Hibery Ho^1*, Elie Traer, MD, PhD⁴, Patrice Lee, PhD^5*, David Chantry, PhD^5*, Brian J. Druker, MD⁴ and Marc Loriaux, MD, PhD^4*

¹Oregon Health & Science University, Portland, OR
²Center for Hematologic Malignancies, Oregon Health & Science University, Portland, OR
³Knight Cancer Institute, Oregon Health & Science University, Portland, OR
⁴Knight Cancer Institute, Division of Hematology and Medical Oncology, Oregon Health & Science University, Portland, OR
⁵Array Biopharma, Boulder, CO

Meral Beksac, MD¹, Pinar Ataca, MD^2*, Berna Atesagaoglu, MD^2*, Klara Dalva^2*, Andry Nur Hidayat^3*, Ismail Yalcin^4*, Esin Yalcin Aki^4*, Tulin Ozkan^5*, Xenofon Papanikalaou^6*, Saad Z Usmani, MD, FACP^6,7 and Erming Tian, PhD⁶

¹Ankara University Faculty of Medicine Department of Hematology, Ankara, Turkey
²Ankara University School of Medicine Department of Hematology, Ankara, Turkey
³Bioinformatics Department, Ankara University Biotechnology Institute, Ankara, Turkey
⁴Department of Pharmaceutical Chemistry, Ankara University Faculty of Pharmacy, Ankara, Turkey
⁵Department of Molecular Medicine and Genetics, Ankara University Faculty of Medicine, Ankara, Turkey
⁶Myeloma Institute, University of Arkansas Medical Sciences, Arkansas
⁷Levine Cancer Institute/Carolinas Healthcare System,, Charlotte, NC

Chengfeng Bi, MD., Ph.D.^1*, Xiaoyan Zhang, MD^2*, Zhang Xuan, MD^1*, Wing C Chan, MD., Ph.D.^3*, Timothy McKeithan, MD., Ph.D.^4* and Kai Fu, MD., Ph.D.⁵

¹Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE
²Department of Pathology and Microbiology and Internal Medicine, University of Nebraska Medical Center, Omaha, NE
³Department of Pathology, City of Hope National Medical Center, Duarte, CA
⁴City of Hope Medical Center, Duarte, CA
⁵Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE